Created as a dedicated organisation, FedEx Life Sciences positions itself as a logistics network for specialised, global, and time-sensitive products from temperature-sensitive therapies and clinical trial materials to medical devices and patient-critical shipments.

In 2025, FedEx secured IATA CEIV Pharma Corporate Certification, achieving corporate-level certification for ground handling across its air hubs and ramps.

FedEx has also expanded its life sciences footprint with a total of six Life Sciences Centers globally.

FedEx executive vice president and chief customer officer, Brie Carere, said: “Healthcare depends on access, and access depends on certainty.

“Every shipment we move in this space has the potential to support a researcher, a physician, a clinician, a caregiver, or most importantly, a patient waiting for care.

“FedEx Life Sciences brings together our global network, advanced monitoring capabilities, and healthcare-focused expertise to help make supply chains smarter and more resilient.”

Additionally, a direct flight between Indianapolis and Dublin has strengthened transatlantic connectivity between these two critical pharmaceutical manufacturing hubs.

These assets are supported by FedEx Surround, a monitoring and intervention service that uses machine learning to provide proactive, end-to-end visibility for critical shipments, identify potential disruptions, and support intervention when timing, temperature, and reliability are essential.

“Healthcare supply chains are becoming more complex, and the stakes are deeply personal,” said Nick Gennari, president of healthcare and life sciences, FedEx.

“FedEx Life Sciences gives our customers a more focused team, stronger coordination, and specialised expertise to help them move critical healthcare shipments with confidence.

“Our role is to provide the certainty, visibility, and global reach healthcare innovators need when every shipment matters.”